Meta-analysis on the validity and clinical utility of the IDF/DAR risk stratification tool
Authors' conclusion
In conclusion, the IDF-DAR Risk Calculator stratifies risk of glycemic complications during Ramadan, distinguishing high- and moderate-risk patients from those at low risk.
Study context
- Population
- Adults with DM assessed with the IDF-DAR Risk Calculator before Ramadan, reporting fasting-related complications; various geographic and care settings5 studies
- Comparison
- IDF-DAR Risk Calculator high- and moderate-risk vs low-risk categories
- Outcome
- Predictive performance for fasting-related complications (hypoglycemia, hyperglycemia) during Ramadan
Methodological detailsPRISMA guidelines, PubMed, Cochrane Library, Google Scholar and Web of Science searched up to March 2025
- PRISMA guidelines
- PubMed, Cochrane Library, Google Scholar and Web of Science searched up to March 2025
Pooled result
As reported in the abstract
Each group vs low-riskEstimate (95 % CI)
High-risk
OR (hypoglycemia) 6.49(1.88–22.46)
High-risk
OR (hyperglycemia) 5.36(2.30–12.57)
Moderate-risk
OR (hypoglycemia) 3.63(2.20–5.98)
Moderate-risk
OR (hyperglycemia) 5.00(1.75–14.32)
Original publication
Meta-analysis on the validity and clinical utility of the IDF/DAR risk stratification tool. Diabetes Res Clin Pract. Published 8 November 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →